However, this waiflike supermodel on the IP publishing scene is always worth a read (or two).Right: Oncomouse (Scott Draves)This issue carries an obituary for the Oncomouse (by Andrew Sharples and Duncan Curley (McDermott Will & Emery's London office), a thoughtful piece on whether German utility model protection is available for biotechnological inventions (by a three-man team from Grund, Munich) and an interesting feature on German businesses reverse-merging into US… [read post]